🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 12/03/2015 | 0,4294 USD |
| 11/12/2014 | 0,4294 USD |
| 11/09/2014 | 0,4198 USD |
| 12/06/2014 | 0,4198 USD |
| 13/03/2014 | 0,4198 USD |
| 12/12/2013 | 0,4198 USD |
| 12/09/2013 | 0,4103 USD |
| 13/06/2013 | 0,4103 USD |
| 13/03/2013 | 0,4103 USD |
| 13/12/2012 | 0,4103 USD |
| 13/09/2012 | 0,4008 USD |
| 13/06/2012 | 0,4008 USD |
| 13/03/2012 | 0,4008 USD |
| 13/12/2011 | 0,4008 USD |
| 13/09/2011 | 0,3626 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 06/08/1992 | 24,99 | 25,11 | 24,81 | 24,81 | -1,19% | 1,19% | 2.755.192 |
| 05/08/1992 | 24,99 | 25,11 | 24,93 | 25,11 | -0,94% | 0,72% | 1.950.328 |
| 04/08/1992 | 25,29 | 25,47 | 25,11 | 25,35 | +0,47% | 1,42% | 3.832.117 |
| 03/08/1992 | 24,69 | 25,23 | 24,63 | 25,23 | +1,93% | 2,42% | 3.818.283 |
| 31/07/1992 | 24,75 | 24,75 | 24,57 | 24,75 | +0,00% | 0,72% | 1.852.654 |
| 30/07/1992 | 24,45 | 24,75 | 24,39 | 24,75 | +1,22% | 1,46% | 2.396.357 |
| 29/07/1992 | 24,45 | 24,69 | 24,33 | 24,45 | +0,49% | 1,46% | 3.598.622 |
| 28/07/1992 | 24,39 | 24,69 | 24,27 | 24,33 | +0,25% | 1,71% | 3.274.371 |
| 27/07/1992 | 23,50 | 24,39 | 23,50 | 24,27 | +3,30% | 3,81% | 4.573.472 |
| 24/07/1992 | 23,20 | 23,50 | 23,20 | 23,50 | +0,25% | 1,29% | 1.967.725 |
| 23/07/1992 | 23,62 | 23,68 | 23,26 | 23,44 | -0,51% | 1,77% | 1.857.056 |
| 22/07/1992 | 23,26 | 23,62 | 23,20 | 23,56 | +0,51% | 1,80% | 2.606.166 |
| 21/07/1992 | 23,68 | 23,74 | 23,26 | 23,44 | -0,51% | 2,02% | 3.408.306 |
| 20/07/1992 | 23,38 | 23,80 | 23,26 | 23,56 | -1,25% | 2,30% | 3.517.298 |
| 17/07/1992 | 23,86 | 23,91 | 23,74 | 23,86 | -0,25% | 0,75% | 3.641.590 |
| 16/07/1992 | 23,68 | 24,03 | 23,62 | 23,91 | +0,50% | 1,76% | 2.697.342 |
| 15/07/1992 | 23,80 | 23,97 | 23,62 | 23,80 | -0,25% | 1,50% | 2.733.603 |
| 14/07/1992 | 23,97 | 23,97 | 23,68 | 23,86 | -0,74% | 1,24% | 2.868.166 |
| 13/07/1992 | 24,15 | 24,15 | 23,91 | 24,03 | +0,00% | 0,99% | 2.259.698 |
| 10/07/1992 | 24,33 | 24,39 | 24,03 | 24,03 | -0,98% | 1,47% | 1.954.939 |
| 09/07/1992 | 24,27 | 24,45 | 24,15 | 24,27 | +0,00% | 1,23% | 3.458.819 |
| 08/07/1992 | 24,03 | 24,33 | 23,97 | 24,27 | +1,24% | 1,49% | 3.420.043 |
| 07/07/1992 | 24,33 | 24,39 | 23,86 | 23,97 | -1,47% | 2,21% | 4.127.024 |
| 06/07/1992 | 23,74 | 24,33 | 23,62 | 24,33 | +3,03% | 3,02% | 4.015.307 |
| 02/07/1992 | 23,74 | 23,86 | 23,38 | 23,62 | -0,25% | 2,01% | 3.610.360 |
| 01/07/1992 | 23,38 | 23,74 | 23,32 | 23,68 | +1,80% | 1,79% | 4.349.829 |
| 30/06/1992 | 23,38 | 23,38 | 22,96 | 23,26 | -0,26% | 1,79% | 3.043.182 |
| 29/06/1992 | 22,72 | 23,38 | 22,66 | 23,32 | +2,89% | 3,15% | 2.952.845 |
| 26/06/1992 | 22,48 | 22,72 | 22,42 | 22,66 | -0,78% | 1,33% | 3.293.026 |
| 25/06/1992 | 23,14 | 23,20 | 22,66 | 22,84 | -0,52% | 2,32% | 3.844.693 |